Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rapid Micro Biosystems (RPID)
NASDAQ:RPID
RPID Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.58 - $4.04
Previous CloseN/A
Volume19.55K
Average Volume (3M)446.85K
Market Cap
$167.83M
Enterprise Value-$15.51M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Feb 28, 2025EPS Estimate
-0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.11
Shares Outstanding37,724,693
10 Day Avg. Volume762,647
30 Day Avg. Volume446,854
Standard Deviation0.25
R-Squared0.06
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.41
Price to Cash Flow (P/CF)-4.90
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.09
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.83
Enterprise Value/Ebitda0.32
Forecast
1Y Price Target
$8.00Price Target Upside118.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Rapid Micro Biosystems News
PremiumCompany Announcements
Rapid Micro Biosystems Reports Record Revenue Growth
PremiumCompany Announcements
Rapid Micro Biosystems Reports Strong Q3 2024 Growth
PremiumCompany Announcements
Rapid Micro Biosystems Reports Record Q3 2024 Revenue---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQ3 revs of $7.6M beat prior guidance and hit a record-high for the company, driven by outperforming product revenues.
Market AdoptionThe company is gaining wide adoption in the biopharmaceutical industry, with a 28% revenue growth from 2022-2024, leading to increased top-line visibility and improving margins.
Product InnovationRapid Micro Bio's Microbial Growth Direct System (GDS) is changing the paradigm in biological manufacturing quality control by being more accurate and providing digital results faster than traditional methods.
Bears Say
Market SaturationRPID's system has 164 installations and is used by 70% of the top 20 biopharmas and Lonza, which could indicate approaching market saturation in top-tier biopharma.
Overreliance On Key CustomersRecord high Q3 revs of $7.6M driven by a multi-system order from existing Top 20 pharma as 'land and expand' strategy continues to materialize, suggesting reliance on a few key customers.
Technology RiskCustomer installations, including those in mission-critical settings, validate the Growth Direct technology, which places high reliance on the system's accuracy and performance.
---
Ownership Overview
26.19% Insiders
2.29% Mutual Funds
26.68% Other Institutional Investors
42.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RPID FAQ
What was Rapid Micro Biosystems’s price range in the past 12 months?
Rapid Micro Biosystems lowest stock price was $0.58 and its highest was $4.04 in the past 12 months.
What is Rapid Micro Biosystems’s market cap?
Rapid Micro Biosystems’s market cap is $167.83M.
When is Rapid Micro Biosystems’s upcoming earnings report date?
Rapid Micro Biosystems’s upcoming earnings report date is Feb 28, 2025 which is in 7 days.
How were Rapid Micro Biosystems’s earnings last quarter?
Rapid Micro Biosystems released its earnings results on Nov 01, 2024. The company reported -$0.26 earnings per share for the quarter, missing the consensus estimate of -$0.255 by -$0.005.
Is Rapid Micro Biosystems overvalued?
According to Wall Street analysts Rapid Micro Biosystems’s price is currently Undervalued.
Does Rapid Micro Biosystems pay dividends?
Rapid Micro Biosystems does not currently pay dividends.
What is Rapid Micro Biosystems’s EPS estimate?
Rapid Micro Biosystems’s EPS estimate is -0.23.
How many shares outstanding does Rapid Micro Biosystems have?
Rapid Micro Biosystems has 37,724,693 shares outstanding.
What happened to Rapid Micro Biosystems’s price movement after its last earnings report?
Rapid Micro Biosystems reported an EPS of -$0.26 in its last earnings report, missing expectations of -$0.255. Following the earnings report the stock price went up 1.852%.
Which hedge fund is a major shareholder of Rapid Micro Biosystems?
Currently, no hedge funds are holding shares in RPID
---
Rapid Micro Biosystems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (118.58% Upside)
$8.00 (118.58% Upside)
Blogger Sentiment
Bullish
RPID Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $41.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
283.90%
12-Months-Change
Fundamentals
Return on Equity
-45.62%
Trailing 12-Months
Asset Growth
-29.52%
Trailing 12-Months
Company Description
Rapid Micro Biosystems
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
---
RPID Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with record revenue and strong system placements, along with significant improvements in gross margins and operational efficiency. Despite ongoing market headwinds and a net loss, the company's strategic initiatives and positive customer engagement indicate a strong position for future growth.Read More>---
RPID Stock 12 Month Forecast
Average Price Target
$8.00
▲(118.58% Upside)
Technical Analysis
Best Analysts Covering RPID
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+151.45%
reiterated a buy rating last month
Copying Brendan Smith's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +151.45% per trade.
---